s'authentifier
version française rss feed
Fiche concise
Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.
Van Poecke S., Munier-Lehmann H., Helynck O., Froeyen M., Van Calenbergh S.
Bioorg Med Chem 19 (2011) epub ahead of print - http://hal-pasteur.archives-ouvertes.fr/pasteur-00645423
(22061826)
Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase.
Sara Van Poecke1, Hélène Munier-Lehmann2, Olivier Helynck2, Matheus Froeyen3, Serge Van Calenbergh1
1 :  Laboratory for Medicinal Chemistry-FWW
Ghent University
Belgique
2 :  Chimie et Biocatalyse
Institut Pasteur de Paris – CNRS : URA2128
25-28 rue du Docteur Roux, 75724 Paris Cedex 15
France
3 :  Rega Institute for Medical Research
Katholieke Universiteit Leuven
Minderbroedersstraat 10;B-3000;Leuven
Belgique
We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'- and 5'-modified thymidine analogues including α- and β-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-α-thymidine analogue being the most active one (K(i)=0.17μM). This compound was capable of inhibiting mycobacteria growth at a concentration of 25μg/mL.
Sciences du Vivant/Biochimie, Biologie Moléculaire
Anglais
1464-3391

Articles dans des revues avec comité de lecture
10.1016/j.bmc.2011.10.021
Bioorg Med Chem
internationale
18/10/2011
18/10/2011
19
epub ahead of print